NZX-listed Blis Technologies, which markets a suite of dental hygiene, vitamin C and throat lozenge products, has downgraded its earnings despite recent expansion into new global markets.
The company today said in a market announcement that it was updating its outlook for the current financial
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
